Covid 19 Vaccine Candidate

Covid 19 Vaccine Candidate News

India has provided COVID-19 vaccines to 71 countries, over six new candidates in offing, says Harsh Vardhan
India

India has provided COVID-19 vaccines to 71 countries, over six new candidates in offing, says Harsh Vardhan

He also said that 1.84 crore COVID-19 vaccine doses have been administered to people so far, while 23 crore tests have been conducted

Harsh Vardhan hails clearance for COVID-19 vaccines as 'watershed moment'; Congress questions 'premature' nod to COVAXIN
India

Harsh Vardhan hails clearance for COVID-19 vaccines as 'watershed moment'; Congress questions 'premature' nod to COVAXIN

India's drugs regulator on Sunday also approved the Oxford University-AstraZeneca COVID-19 vaccine 'Covishield', manufactured by the Serum Institute for restricted emergency use in the country, paving the way for a massive inoculation drive

India in talks with Moderna over COVID-19 vaccine development after biotech firm says its candidate shows 95% efficacy
India

India in talks with Moderna over COVID-19 vaccine development after biotech firm says its candidate shows 95% efficacy

'We are also in dialogue with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila for their vaccine candidate in terms of safety, immunogenicity and efficacy,' a government official said

Daily COVID-19 recoveries exceed new cases; study finds 31% young adults faced anxiety during lockdown
India

Daily COVID-19 recoveries exceed new cases; study finds 31% young adults faced anxiety during lockdown

As COVID-19 cases continued to rise in Maharashtra, former chief minister Devendra Fadnavis announced on Saturday said that he had tested positive for the novel coronavirus

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials
India

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.

China leading COVID-19 vaccine research globally, says govt after Jair Bolsonaro's 'guinea pig' jibe
World

China leading COVID-19 vaccine research globally, says govt after Jair Bolsonaro's 'guinea pig' jibe

On Wednesday, Brazilian president Bolsonaro, cancelling plans to buy a potential COVID-19 vaccine from China, said Brazilians will not be “anyone’s guinea pig”

Oxford COVID-19 vaccine performing as 'expected', successfully induces immune response, says independent study
World

Oxford COVID-19 vaccine performing as 'expected', successfully induces immune response, says independent study

The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus

Johnson & Johnson halts COVID-19 vaccine trial after participant develops 'unexplained illness'
World

Johnson & Johnson halts COVID-19 vaccine trial after participant develops 'unexplained illness'

The J&J Phase 3 trial had started recruiting participants in September 2020, with a goal of enrolling up to 60,000 volunteers across more than 200 sites in the US and around the world

COVID-19 vaccine: Serum Institute of India to begin Phase 2 trial of Oxford-Astrazeneca candidate today
India

COVID-19 vaccine: Serum Institute of India to begin Phase 2 trial of Oxford-Astrazeneca candidate today

The DCGI on 3 August had given nod to the Pune Serum Institute of India for conducting phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost
India

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost

Hyderabad-based Bharat Biotech, one of seven Indian companies involved in the indigenous production of a vaccine for the novel coronavirus, received the green signal from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of 'Covaxin' last week.